Data / Drug companies / Makeup Art Cosmetics
Makeup Art Cosmetics: 7 products in the FDA NDC directory, labeler code 40046
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Makeup Art Cosmetics (labeler code 40046) lists 7 products in the FDA National Drug Code Directory, covering 3 finished drugs by generic name. By type: 5 over the counter drugs, 2 drugs for further processing. Its main marketing category is over the counter monograph drugs. The newest product started marketing on December 25, 2024.
The request: Watch Makeup Art Cosmetics (FDA labeler code 40046): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 40046
- Products in commercial distribution
- 7
- Packages
- 12
- Finished drugs by generic name
- 3
- Prescription products
- 0
- Over the counter products
- 5
- Flagged as original packager
- 5 of 5 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- December 1, 2005
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 5 | 71.4% |
| Drugs for further processing | 2 | 28.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 5 | 71.4% |
| Drugs for further processing | 2 | 28.6% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Octinoxate and titanium dioxide | 2 | 10 |
| Octinoxate, titanium dioxide | 1 | 10 |
| Octinoxate, titanium dioxide, and zinc oxide | 1 | 4 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 3 | 42.9% |
| Emulsion | 2 | 28.6% |
| Paste | 1 | 14.3% |
| Lotion | 1 | 14.3% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Octinoxate, titanium dioxide | 40046-0901 | Emulsion | Drugs for further processing | December 25, 2024 |
| Octinoxate and titanium dioxide | 40046-0900 | Liquid | Drugs for further processing | December 25, 2024 |
| Studio fix fluid broad spectrum spf 15 | 40046-0082 | Emulsion | Over the counter monograph drugs | May 12, 2023 |
| Mac studio waterweight spf 30 broad spectrum foundation sunscreen | 40046-0075 | Liquid | Over the counter monograph drugs | August 1, 2015 |
| Mac prep and prime face protect broad spectrum spf 50 | 40046-0063 | Lotion | Over the counter monograph drugs | February 2, 2012 |
| Studio finish concealer broad spectrum spf 35 | 40046-0078 | Paste | Over the counter monograph drugs | August 8, 2011 |
| Studio fix fluid spf 15 broad spectrum | 40046-0072 | Liquid | Over the counter monograph drugs | December 1, 2005 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.